These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 22115795

  • 21. A specific inhibitor of polo-like kinase 1, GSK461364A, suppresses proliferation of Raji Burkitt's lymphoma cells through mediating cell cycle arrest, DNA damage, and apoptosis.
    Ergul M, Bakar-Ates F.
    Chem Biol Interact; 2020 Dec 01; 332():109288. PubMed ID: 33075310
    [Abstract] [Full Text] [Related]

  • 22. In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1.
    Lansing TJ, McConnell RT, Duckett DR, Spehar GM, Knick VB, Hassler DF, Noro N, Furuta M, Emmitte KA, Gilmer TM, Mook RA, Cheung M.
    Mol Cancer Ther; 2007 Feb 01; 6(2):450-9. PubMed ID: 17267659
    [Abstract] [Full Text] [Related]

  • 23. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y, Du XL, Wang CJ, Lin DC, Ruan X, Feng YB, Huo YQ, Peng H, Cui JL, Zhang TT, Wang YQ, Zhang H, Zhan QM, Wang MR.
    Gastroenterology; 2012 Mar 01; 142(3):521-530.e3. PubMed ID: 22108192
    [Abstract] [Full Text] [Related]

  • 24. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R, Chandna S, N Kapoor P, S Dwarakanath B.
    Curr Cancer Drug Targets; 2011 Mar 01; 11(3):380-92. PubMed ID: 21247380
    [Abstract] [Full Text] [Related]

  • 25. 5'-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling.
    Yoon JH, Kim SA, Kwon SM, Park JH, Park HS, Kim YC, Yoon JH, Ahn SG.
    Biochim Biophys Acta; 2010 Mar 01; 1800(3):352-8. PubMed ID: 19914349
    [Abstract] [Full Text] [Related]

  • 26. The peptidyl-prolyl isomerase Pin1.
    Joseph JD, Yeh ES, Swenson KI, Means AR, Winkler.
    Prog Cell Cycle Res; 2003 Mar 01; 5():477-87. PubMed ID: 14593743
    [Abstract] [Full Text] [Related]

  • 27. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.
    Pezuk JA, Brassesco MS, Morales AG, de Oliveira JC, de Paula Queiroz RG, Machado HR, Carlotti CG, Neder L, Scrideli CA, Tone LG.
    Cancer Gene Ther; 2013 Sep 01; 20(9):499-506. PubMed ID: 23887645
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
    Liu X, Choy E, Harmon D, Yang S, Yang C, Mankin H, Hornicek FJ, Duan Z.
    Anticancer Drugs; 2011 Jun 01; 22(5):444-53. PubMed ID: 21399492
    [Abstract] [Full Text] [Related]

  • 29. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.
    Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto AJ, Bagella L, Castronovo M, Giordano A.
    Cell Death Differ; 2012 Jul 01; 19(7):1152-61. PubMed ID: 22322860
    [Abstract] [Full Text] [Related]

  • 30. 5'-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling.
    Kim SA, Kwon SM, Kim JA, Kang KW, Yoon JH, Ahn SG.
    Cancer Lett; 2011 Jul 28; 306(2):197-204. PubMed ID: 21463917
    [Abstract] [Full Text] [Related]

  • 31. Enhanced gemcitabine-mediated cell killing of human lung adenocarcinoma by vector-based RNA interference against PLK1.
    Zhao XY, Nie CL, Liang SF, Yuan Z, Deng HX, Wei YQ.
    Biomed Pharmacother; 2012 Dec 28; 66(8):597-602. PubMed ID: 23153503
    [Abstract] [Full Text] [Related]

  • 32. Inhibiting polo-like kinase 1 enhances radiosensitization via modulating DNA repair proteins in non-small-cell lung cancer.
    Yao D, Gu P, Wang Y, Luo W, Chi H, Ge J, Qian Y.
    Biochem Cell Biol; 2018 Jun 28; 96(3):317-325. PubMed ID: 29040814
    [Abstract] [Full Text] [Related]

  • 33. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
    Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE.
    Stem Cells; 2012 Jun 28; 30(6):1064-75. PubMed ID: 22415968
    [Abstract] [Full Text] [Related]

  • 34. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P, Yun HJ, Lim SC, Ahn SG, Yoon HE, Kang KW, Hong R, Choi HS.
    Oncogene; 2012 Aug 23; 31(34):3845-56. PubMed ID: 22158035
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
    McCarroll JA, Dwarte T, Baigude H, Dang J, Yang L, Erlich RB, Kimpton K, Teo J, Sagnella SM, Akerfeldt MC, Liu J, Phillips PA, Rana TM, Kavallaris M.
    Oncotarget; 2015 May 20; 6(14):12020-34. PubMed ID: 25557168
    [Abstract] [Full Text] [Related]

  • 36. Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage.
    Tong Y, Ying H, Liu R, Li L, Bergholz J, Xiao ZX.
    Cell Death Dis; 2015 Feb 12; 6(2):e1640. PubMed ID: 25675300
    [Abstract] [Full Text] [Related]

  • 37. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma.
    Stehle A, Hugle M, Fulda S.
    Cancer Lett; 2015 Aug 28; 365(1):37-46. PubMed ID: 25917079
    [Abstract] [Full Text] [Related]

  • 38. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G, Khanal P, Kim JY, Yun HJ, Lim SC, Shim JH, Choi HS.
    Mol Carcinog; 2015 Jun 28; 54(6):440-8. PubMed ID: 24265246
    [Abstract] [Full Text] [Related]

  • 39. Rapid functional screening of effective siRNAs against Plk1 and its growth inhibitory effects in laryngeal carcinoma cells.
    Lan H, Zhu J, Ai Q, Yang Z, Ji Y, Hong S, Song F, Bu Y.
    BMB Rep; 2010 Dec 28; 43(12):818-23. PubMed ID: 21189159
    [Abstract] [Full Text] [Related]

  • 40. Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.
    Hu K, Lee C, Qiu D, Fotovati A, Davies A, Abu-Ali S, Wai D, Lawlor ER, Triche TJ, Pallen CJ, Dunn SE.
    Mol Cancer Ther; 2009 Nov 28; 8(11):3024-35. PubMed ID: 19887553
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.